First genetically-engineered malaria vaccine to enter human trials
Tuesday, July 28, 2009 - 16:35
in Health & Medicine
Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year.